ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Harmony Biosciences Receives FDA Approval for Expanded Use of WAKIX
October 21, 2020Harmony Biosciences announced the U.S. Food and Drug Administration (FDA) has approved WAKIX® (pitolisant) for the treatment of cataplexy in adult patients with narcolepsy. -
Harmony Biosciences Announces FDA Approval of WAKIX
August 16, 2019Harmony Biosciences announced the U.S. Food and Drug Administration (FDA) approved WAKIX® (pitolisant) for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy. -
FDA Approves Wakix (pitolisant), a First-in-Class Medication for the Treatment of Excessive Daytime Sleepiness in Adult Patients with Narcolepsy
August 16, 2019Harmony Biosciences, LLC (Harmony) announced today that the U.S. Food and Drug Administration (FDA) approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy.
Pharma Sources Insight January 2025
